Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026Appointments Corporate, Corporate
Ramil Burden is the new Chief Executive Officer of Acumetis, announced the company in a recent statement. Founder and CEO …
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
October 27, 2026Chronic Diseases, EMA, Pain, Pharmacy, drug development, regulatory
Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use …
Hot-tub therapy tested as potential treatment for peripheral artery disease
October 26, 2026Cardiology, PAD, Pain, cardiology
Researchers at Manchester Metropolitan University are investigating whether regular hot-water immersion can improve mobility and relieve pain in people with …
Raimond takes helm at Nuclera
October 26, 2026Biotechnology, Diagnostics, appointments
Nuclera, the biotechnology company enabling access to innovative protein technologies, has appointed Carl Raimond as Chief Executive Officer, effective immediately. …
Most advanced breast cancer patients treated in community settings, Phesi study finds
October 26, 2026Oncology, breast cancer, clinical trials, community healthcare, oncology
Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings rather than academic centres, potentially …
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
October 23, 2026Diabetes, Obesity, Peptide therapies, clinical trials, diabetes, weight reduction
Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose than oral semaglutide in adults …
Bramacare opens supported-living facility for eating disorder recovery
October 23, 2026Psychiatry, eating disorders, supported living
Bramacare has opened a new facility in Ipswich offering supported living for adults recovering from complex eating disorders, providing a …
Aiforia deal to expand access to pathology AI
October 22, 2026AI, Corporate, Devices, Hospital Management, commercial agreements, digital pathology
Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital pathology available to …
SMC accepts atogepant for acute migraine treatment in Scotland
October 22, 2026Neurology, SMC, clinical trial, migraine
The Scottish Medicines Consortium (SMC) has accepted AbbVie’s Aquipta (atogepant) as an option for the acute treatment of migraine with …
New CCO Ogburn joins Cori Clinical
October 21, 2026Corporate, Data Capture, Pharmacy, pharmaceutical, regulatory
Cori Clinical has announced the appointment of Dr Emma Ogburn as Chief Clinical Officer. She joins Cori’s founding team of …
Claris reports visual acuity gains with experimental LSCD treatment
October 21, 2026Opthalmology, cytology, ophthalmics
Claris Biotherapeutics has reported visual acuity improvements with its experimental therapy CSB-001 in a proof-of-concept study involving patients with limbal …
Amphista doses first patient in AML trial of protein degrader
October 20, 2026AML, FDA, Oncology, clinical trial, drug development, pharma
Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an experimental oral therapy targeting acute …
First 90 days of antipsychotic treatment linked to rapid metabolic changes
October 20, 2026Diabetes, NIHR, Psychiatry, UCL, antipsychotic drugs, diabetes, mental health, mental illness
The first 90 days after starting antipsychotic treatment are a critical period for monitoring blood glucose and weight, according to …
Jennings becomes President of Beckman Coulter Diagnostics
October 19, 2026Beckman Coulter Diagnostics, Corporate, Diagnostics, appointments
Beckman Coulter Diagnostics has appointed Catherine Jennings as its new President. In this role, Jennings will lead the company’s strategic, …
Digital platform cuts pharmaceutical quality-record approval times by up to 90%
October 19, 2026Pharmacovigilance, Regulatory Affairs Devices, Hospital Management, certification, digitalisation, pharmaceutical, regulatory, supply chain
A digital platform for exchanging pharmaceutical quality records between supply-chain partners is now commercially available, following an Innovate UK-funded project …
Boyds expands Regulatory Affairs team to support growing demand
October 16, 2026Consultancy, Diagnostics, Pharmacy, drug development, life sciences, regulatory affairs
Vicki Hayes has joined Boyds as Vice President of Regulatory Affairs with Jan Ohotski becoming Director of Regulatory Affairs. Hayes …
Sterling doubles ADC manufacturing capacity at Welsh facility
October 16, 2026ADCs, Corporate, HPLC, Immunology, Infections and infestations, Oncology, manufacturing
Sterling Pharma Solutions has completed a multi-million-pound expansion of its dedicated bioconjugation facility in Deeside, Wales, doubling manufacturing capacity and …
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026Devices, Diagnostics, Hospital Management, Oncology, laser imaging, lung disease, tumour
Femtosecond laser imaging has reduced the time needed to assess lung tumour margins from 36 minutes to less than six …
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
October 15, 2026Diagnostics, Haematology, Neurological Diseases, Neurology, Parkinson's disease, blood testing, sleep disorder
Researchers at King Abdullah University of Science and Technology (KAUST) and the University of Oxford have developed a blood-based electronic …
Cori Clinical raises US$4m to expand AI platform for clinical trial design
October 14, 2026AI, Data Capture, Pharmacy, clinical data, clinical trial design, regulatory affairs
Cori Clinical has raised US$4m in a seed funding round to expand its AI platform for clinical trial design and …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
